MarketPulse

women's health

2 articles
The Motley FoolThe Motley Fool··Jonathan Ponciano

Major Investor Bet on Organon Stock Signals Turnaround Faith Despite 61% Collapse

Sio Capital Management invested $24.53 million in Organon ($OGN) at $6.03/share, betting on turnaround potential despite 61% annual decline. Company maintains flat 2026 guidance with $1.9B adjusted EBITDA.
OGNvalue investinginstitutional investment
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider Research

Uterine Fibroid Treatment Market Poised for 7.63% Annual Growth Through 2033

Global uterine fibroid treatment market projected to grow 7.63% annually through 2033, reaching $9.43 billion. Growth driven by high disease prevalence and minimally invasive surgical advances.
JNJPFEABBVSYKMDT+9market growthminimally invasive procedures